# Radiation Therapy and IRreversible Electroporation for Intermediate Risk Prostate Cancer (RTIRE)

> **NCT05345444** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Weill Medical College of Cornell University** · enrollment: 48 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DEVICE:** IRE & MRgRT

## Key facts

- **NCT ID:** NCT05345444
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-05-26
- **Primary completion:** 2026-05
- **Final completion:** 2027-09
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2026-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05345444

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05345444, "Radiation Therapy and IRreversible Electroporation for Intermediate Risk Prostate Cancer (RTIRE)". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT05345444. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*